Published in Gut on February 01, 1967
DEFECTS IN HEPATIC TRANSPORT OF BILIRUBIN IN CONGENITAL HYPERBILIRUBINAEMIA: AN ANALYSIS OF PLASMA BILIRUBIN DISAPPEARANCE CURVES. Clin Sci (1964) 2.50
IDIOPATHIC RECURRENT CHOLESTASIS: A STUDY OF THE FUNCTIONAL AND PATHOLOGICAL LESIONS IN FOUR CASES. Q J Med (1964) 1.26
THE SYNDROME OF BENIGN RECURRENT CHOLESTASIS. Am J Med (1965) 1.19
Contribution to the identification of bile pigments in normal human serum. Scand J Clin Lab Invest (1962) 1.09
Intermittent possibly familial intrahepatic cholestatic jaundice. Lancet (1960) 1.03
NORMAL BILIRUBIN CONCENTRATION AND THE OCCURRENCE OF OTHER BILE PIGMENTS IN HUMAN BLOOD SERA. Scand J Clin Lab Invest (1963) 0.96
A specific method for quantitative determination of unconjugated bilirubin and mesobilirubin. Scand J Clin Lab Invest (1963) 0.90
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl (1966) 2.03
Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology (1984) 1.95
Bilirubin colloid formation in neutral aqueous solution. Scand J Clin Lab Invest (1969) 1.93
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol (1986) 1.57
Binding of bilirubin to albumin. CRC Crit Rev Clin Lab Sci (1980) 1.43
A simple method for determination of antipyrine clearance. Clin Pharmacol Ther (1982) 1.41
Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem (1979) 1.39
Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery. Eur J Clin Pharmacol (1993) 1.39
Comparison of the bilirubin concentration and the bilirubin/albumin ration with the bilirubin-binding ability in neonatal serum. J Pediatr (1998) 1.38
Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology (1980) 1.33
Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol (1976) 1.31
Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation. J Clin Invest (1974) 1.30
Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis (1986) 1.29
Solubility of long-chain fatty acids in phosphate buffer at pH 7.4. Biochim Biophys Acta (1992) 1.26
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology (1981) 1.25
Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation (1986) 1.24
The Lugano statements on controlled clinical trials. J Int Med Res (1987) 1.23
Clearance of antipyrine-dependence of quantitative liver function. Eur J Clin Invest (1974) 1.19
Photooxidation of human serum albumin and its complex with bilirubin. Eur J Biochem (1977) 1.19
Treatment of acute viral hepatitis with (+)-cyanidanol-3. Lancet (1977) 1.18
Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut (1976) 1.13
Enzymatic oxidation of bilirubin. Eur J Biochem (1969) 1.10
Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. Acta Med Scand (1969) 1.10
Intramolecular hydrogen bonding in bilirubin. Acta Chem Scand (1967) 1.08
Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology (1983) 1.06
Enzymatic elimination of substrates flowing through the intact liver. J Theor Biol (1976) 1.06
Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology (1980) 1.06
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology (1993) 1.03
Glycerol metabolism in the human liver: inhibition by ethanol. Science (1965) 1.03
Localization of bilirubin pools in the non-jaundiced rat, with a note on bilirubin dynamics in normal human adults and in Gilbert's syndrome. Scand J Clin Lab Invest (1972) 1.00
Albumin-bilirubin binding mechanism. J Biol Chem (1983) 0.99
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut (1985) 0.98
High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs (1992) 0.97
Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin). Pharmacol Toxicol (2001) 0.96
Bilirubin acidity. Titrimetric and 13C NMR studies. Acta Chem Scand B (1979) 0.96
Effect of sites of blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest (1977) 0.95
Fulminant hepatic failure. Clin Gastroenterol (1981) 0.93
Autoprotection in acetaminophen intoxication in rats: the role of liver regeneration. Pharmacol Toxicol (2001) 0.92
Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. Mol Pharmacol (1984) 0.92
Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand (1983) 0.92
Bilirubin diglucuronide in normal human blood serum. Scand J Clin Lab Invest (1966) 0.92
The epidemiology of the gastrointestinal randomized clinical trial. N Engl J Med (1977) 0.91
Displacement of albumin-bound bilirubin by fatty acids. Acta Paediatr Scand (1972) 0.90
The physiologic basis for clearance measurements in hepatology. Scand J Gastroenterol (1979) 0.90
Prevention of kernicterus, based on recent progress in bilirubin chemistry. Acta Paediatr Scand (1977) 0.89
Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study. Eur J Pediatr (1993) 0.89
Skin colour and bilirubin in neonates. Arch Dis Child (1989) 0.89
Determination of the hepatic blood flow in man by simultaneous use of five test substances measured in two parts of the liver. Scand J Clin Lab Invest (1965) 0.89
Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance. Hepatology (1985) 0.89
Pig liver perfusion in the treatment of acute hepatic failure. Scand J Gastroenterol Suppl (1971) 0.89
Liver function and blood flow in normal man during infusion of vasopressin. Scand J Clin Lab Invest (1969) 0.89
Main causes of death in cirrhosis. Scand J Gastroenterol (1983) 0.88
Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology (1983) 0.88
Plasma cyclic AMP and total catecholamines during acute myocardial infarction in man. Eur J Clin Invest (1974) 0.88
Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharmacol Toxicol (1996) 0.88
Bilirubin transport in the newborn infant, reviewed with relation to kernicterus. J Pediatr (1980) 0.87
Drug-induced displacement of bilirubin from albumin in the newborn. Dev Pharmacol Ther (1983) 0.87
Prediction of hepatic encephalopathy in paracetamol overdose: a prospective and validated study. Scand J Gastroenterol (1999) 0.87
Binding of bilirubin and long-chain fatty acids to human serum albumin with general remarks on displacement of firmly bound ligands. Scand J Clin Lab Invest (1977) 0.87
Independent binding of ligands to human serum albumin. J Biol Chem (1977) 0.86
Detection of carrier heterogeneity by rate of ligand dialysis: medium-chain fatty acid interaction with human serum albumin and competition with chloride. Anal Biochem (1988) 0.86
The increase of yellow skin colour beyond that of serum bilirubin: a proposed indicator of risk for bilirubin encephalopathy in the newborn. Acta Paediatr Jpn (1993) 0.86
Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol (1984) 0.85
Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand (1991) 0.85
Bilirubin-liposome interaction. Binding of bilirubin dianion, protonization, and aggregation of bilirubin acid. J Biol Chem (1981) 0.85
Serum Gc-globulin in the early course of multiple trauma. Crit Care Med (1998) 0.85
Laurate binding to human serum albumin. Multiple binding equilibria investigated by a dialysis exchange method. Eur J Biochem (1986) 0.84
Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC. Hum Genet (1999) 0.84
Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev (1982) 0.84
Bilirubin-displacing effect of furosemide and sulfisoxazole. An in vitro and in vivo study in neonatal serum. Dev Pharmacol Ther (1983) 0.84
Thermodynamic parameters for binding of fatty acids to human serum albumin. Eur J Biochem (1990) 0.83
Albumin synthesis rate as a measure of liver function in patient with cirrhosis. Acta Med Scand (1967) 0.83
Cobinding of bilirubin and sulfonamide and of two bilirubin molecules to human serum albumin: a site model. Arch Biochem Biophys (1987) 0.83
Hepatic, renal, and total body galactose elimination in the pig. Am J Physiol (1993) 0.83
THE ELIMINATION OF PENICILLIN G IN BILATERALLY NEPHRECTOMIZED DOGS. J Clin Invest (1949) 0.83
The hepatic metabolism of ethanol in patients with cirrhosis of the liver. Scand J Clin Lab Invest (1969) 0.83
Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy: evaluation of indocyanine green and D-sorbitol as test substances. Hepatology (1998) 0.83
Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats. Hepatology (1997) 0.82
Effect of dietary protein on the capacity of urea synthesis in rats. Horm Metab Res (1990) 0.82
Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroenterol (1981) 0.82
Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol (1981) 0.82
Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis. Hepatology (1999) 0.82
Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol (1995) 0.82
Anti-inflammatory treatment of chronic active liver disease. Prog Liver Dis (1970) 0.82
Determination of reserve albumin-equivalent for ligand binding, probing two distinct binding functions of the protein. Anal Biochem (1982) 0.82
Treatment of duodenal ulcer. Randomized clinical trials of a decade (1964 to 1974). Gastroenterology (1977) 0.81
Effects of LPS on transport of indocyanine green and alanine uptake in perfused rat liver. Am J Physiol (1999) 0.81
A liver factor increasing glucose uptake in rat hindquarters. J Hepatol (1994) 0.81
Early features of primary biliary cirrhosis: an analysis of 85 patients. Am J Gastroenterol (1985) 0.81
The effects of azathioprin in patients with cirrhosis of the liver. Scand J Gastroenterol Suppl (1970) 0.81
Effect of drug combinations on bilirubin-albumin binding. Dev Pharmacol Ther (1991) 0.80
The relation between function and perfusion of the isolated pig liver. Scand J Gastroenterol Suppl (1971) 0.80
Liver function and blood flow at high altitude. J Appl Physiol (1970) 0.80
Kinetics of bilirubin oxidation with peroxidase, as applied to studies of bilirubin-albumin binding. Scand J Clin Lab Invest (1979) 0.80
The prognostic value of laboratory tests in liver disease. Scand J Gastroenterol Suppl (1973) 0.80
Comparison of the binding characteristics of serum albumins from various animal species. Dev Pharmacol Ther (1990) 0.80
Two-dimensional electrophoresis of the fatty acid binding protein from human heart: evidence for a thiol group which can form an intermolecular disulfide bond. Electrophoresis (1990) 0.80
Kernicterus research and the basic sciences: a prospect for future development. Pediatrics (1987) 0.79